StockData
Moderna, Inc. logo

Moderna, Inc. (MRNA) stock

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30537% above fair value
$206.80−8.47 (-3.93%)

Close on Nov 17, 2026Market cap $82.56BP/E –Yield –

Moderna profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Moderna's profit margin for the twelve months ending Jun 30, 2026 was -141.4%. For fiscal 2025 it was -145.2%, against -110.0% the year before. The highest annual figure on record is 66.1% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-145.2%−35.1
FY2024Dec 31, 2024-110.0%−41.2
FY2023Dec 31, 2023-68.8%−112.2
FY2022Dec 31, 202243.4%−22.7
FY2021Dec 31, 202166.1%+159.1
FY2020Dec 31, 2020-93.0%+763.6
FY2019Dec 31, 2019-856.7%−571.8
FY2018Dec 31, 2018-284.8%−160.5
FY2017Dec 31, 2017-124.3%+75.1
FY2016Dec 31, 2016-199.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-539.3%+41.7
Q1 FY2026Mar 31, 2026-345.2%+553.8
Q4 FY2025Dec 31, 2025-121.8%−5.9
Q3 FY2025Sep 30, 2025-19.7%−20.4
Q2 FY2025Jun 30, 2025-581.0%−50.3
Q1 FY2025Mar 31, 2025-899.1%−195.5
Q4 FY2024Dec 31, 2024-115.9%−123.7
Q3 FY2024Sep 30, 20240.7%+199.0
Q2 FY2024Jun 30, 2024-530.7%−129.5
Q1 FY2024Mar 31, 2024-703.6%−707.8
Q4 FY2023Dec 31, 20237.7%−21.1
Q3 FY2023Sep 30, 2023-198.3%−229.3
Q2 FY2023Jun 30, 2023-401.2%−447.4
Q1 FY2023Mar 31, 20234.2%−56.0
Q4 FY2022Dec 31, 202228.8%−38.7
Q3 FY2022Sep 30, 202231.0%−36.1
Q2 FY2022Jun 30, 202246.3%−17.6
Q1 FY2022Mar 31, 202260.3%−2.7
Q4 FY2021Dec 31, 202167.5%+115.3
Q3 FY2021Sep 30, 202167.1%+215.5
Q2 FY2021Jun 30, 202163.8%+238.5
Q1 FY2021Mar 31, 202163.0%+1613.0
Q4 FY2020Dec 31, 2020-47.8%+829.2
Q3 FY2020Sep 30, 2020-148.4%+574.4
Q2 FY2020Jun 30, 2020-174.6%+856.8
Q1 FY2020Mar 31, 2020-1550.0%−722.7
Q4 FY2019Dec 31, 2019-877.0%−477.8
Q3 FY2019Sep 30, 2019-722.8%−530.5
Q2 FY2019Jun 30, 2019-1031.4%−717.4
Q1 FY2019Mar 31, 2019-827.3%−578.1
Q4 FY2018Dec 31, 2018-399.3%–
Q3 FY2018Sep 30, 2018-192.4%–
Q2 FY2018Jun 30, 2018-314.0%–
Q1 FY2018Mar 31, 2018-249.2%–

More Moderna figures

See a number that looks wrong?